Amelia M Marie Jernigan

Dr. Amelia M Marie Jernigan


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2014 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
AJAmelia M Marie Jernigan
Amelia M Marie Jernigan
CCChi Chiung Grace Chen
Chi Chiung Grace Chen
CSCatherine Sewell
Catherine Sewell

1 January 2016 in Journal of Lower Genital Tract Disease
Verified
Journal Article
Closed access
KLKimberly L. Levinson
Kimberly L. Levinson
AJAmelia M Marie Jernigan
Amelia M Marie Jernigan
SFSusan A. Flocke
Susan A. Flocke
ATAna I. Tergas
Ana I. Tergas
CGCamille C. Gunderson
Camille C. Gunderson
JBJerome L. Belinson
Jerome L. Belinson
Objectives The aims of the study were to examine barriers to cervical cancer screening among women who have experienced intimate partner violence (IPV) and accessed domestic violence shelters, to compare barriers among those up-to-date (UTD) and not UTD on screening, and to evaluate acceptability of human papillomavirus self-sampling. Materials and Methods This is a cross-sectional survey in which domestic violence shelters in Ohio were identified and women completed an anonymous survey assessing UTD screening status, barriers related to screening, history of IPV, intention to follow up on abnormal screening, and acceptability of self-sampling. Characteristics of UTD and not UTD women were compared using Mann-Whitney U tests. Results A total of 142 women from 11 shelters completed the survey. Twenty-three percent of women were not UTD. Women who were not UTD reported more access-related barriers (mean = 2.2 vs 1.8; p = .006). There was no difference in reported IPV-related barriers between women who were not UTD and those who are UTD (mean = 2.51 in not UTD vs 2.24 in UTD; p = .13). Regarding future screening, of the women who expressed a preference, more women not UTD preferred self-sampling than UTD women (32% vs 14%; p = .05). Conclusions In this study, access-related barriers were more commonly reported among women not UTD with screening. Addressing these barriers at domestic violence shelters may improve screening among not UTD women. Self-sampling may also be one feasible approach to support screening in this population.

1 September 2015 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
AJAmelia M Marie Jernigan
Amelia M Marie Jernigan
KMKathryn A. Maurer
Kathryn A. Maurer
KCKaren Cooper
Karen Cooper
PSPhilip R. Schauer
Philip R. Schauer
PRPeter G. Rose
Peter G. Rose
CMChad M. Michener
Chad M. Michener

31 August 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
RRRobert C. Ross
Robert C. Ross
YAYetunde M. Akinde
Yetunde M. Akinde
PSPhilip R. Schauer
Philip R. Schauer
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
DBDonal J Brennan
Donal J Brennan
VAVance L Albaugh
Vance L Albaugh
The obesity pandemic continues to contribute to a worsening burden of disease worldwide. The link between obesity and diseases such as diabetes, cardiovascular disease, and cancer has been well established, yet most patients living with obesity remain untreated or undertreated. Metabolic and bariatric surgery is the most effective and durable treatment for obesity, is safe, and may have a protective benefit with respect to cancer incidence. In this review, an overview of the link between obesity, metabolic surgery, and cancer is discussed with emphasis on indications for endometrial cancer, the malignancy most strongly associated with obesity. Considerable evidence from retrospective and prospective cohort studies supports a decreased risk of endometrial cancer in patients with obesity who undergo bariatric surgery compared with nonsurgical controls. Survivors of endometrial cancer are at increased risk of poor health outcomes associated with obesity, and women with endometrial cancer are more likely to die of cardiovascular disease and other obesity-related illnesses than of the malignancy itself. Recent advances in anticancer drug therapies have targeted pathways that may also be therapeutically altered with metabolic surgery. Metabolic surgery has significant potential to enter the treatment paradigm for endometrial cancer, and gynecologic oncologist visits present an opportunity to identify patients who may benefit the most.

7 August 2022 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
MBMorgan L. Brown
Morgan L. Brown
VSVidda Simpson
Vidda Simpson
ACAnnabelle B. Clark
Annabelle B. Clark
MMMargarite Matossian
Margarite Matossian
SHStacey L. Holman
Stacey L. Holman
NNNavya Nair
Navya Nair

1 July 2015 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
CDChristopher C. DeStephano
Christopher C. DeStephano
AJAmelia M Marie Jernigan
Amelia M Marie Jernigan
LSLinda M. Szymanski
Linda M. Szymanski